Analytical Data
-
Gene name
C1orf110
- Application
-
Alternative Names
CCDC190; C1orf110; Coiled-coil domain-containing Protein 190
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q86UF4
-
Expression Region
1-302aa
-
AA Sequence
MERHMVRGQL YKHFDLERKN AKQAEARLDQ RLQRLKVICL YHVKLLTWEQ RQLQKELQRL QQAETMKKKF SSYLGNGFQK RPEDVLVFSP QGRQKHRAPQ AKKMRALATR MAQDTCKSKS QVPPSHDAGL KDPMKSKKQP LSQNNRTACF IKEQPQAQEK DSVNPSKDVD PSKGISVPCQ NQEVSTNTIE QGPSSSPASD SGMACADETR SKDVALKPDG NTGKQIPPKH MECAGSFEGE FTKPTFLELL SKARNAHYLR HRVPPESERL LSIGEIFGHG ESSSSRAGKE CENRVPSKFL PL
-
Molecular Weight
34.1kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf110, also known as “Chromosome 1 Open Reading Frame 110,” is a protein that has garnered attention in recent years due to its potential implications in various biological processes and diseases. As a member of the extended protein family involved in cancer and cellular regulation, C1orf110 has been implicated in crucial cellular functions, including cell proliferation, differentiation, and apoptosis. Research suggests that aberrant expression of C1orf110 may be associated with tumorigenesis, particularly in certain cancer types, highlighting its role as a potential biomarker or therapeutic target. Furthermore, studies have indicated its involvement in immune responses and neurodevelopment, making it a protein of interest in both oncology and immunology. The recombinant expression of C1orf110 allows for detailed biochemical characterization and functional studies, which can elucidate its mechanism of action and role in pathophysiological conditions. Understanding the structure and function of C1orf110 through recombinant protein research may unveil novel insights into its biological significance, paving the way for the development of targeted therapies and advanced diagnostic tools. As such, C1orf110 represents a compelling subject for ongoing research in cellular biology and disease mechanisms, with potential applications in precision medicine.
